Filing Details

Accession Number:
0001651308-19-000104
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-06 18:50:21
Reporting Period:
2019-11-04
Accepted Time:
2019-11-06 18:50:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651308 Beigene Ltd. BGNE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1374068 Yung-Cheng Timothy Chen C/O Mourant Governance Services (Cayman)
94 Solaris Avenue
Camana Bay, Grand Cayman E9 KY1-1108
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
American Depositary Shares Acquisiton 2019-11-04 4,000 $41.01 4,000 No 4 M Direct
American Depositary Shares Disposition 2019-11-04 1,200 $189.37 2,800 No 4 S Direct
American Depositary Shares Disposition 2019-11-04 1,394 $190.34 1,406 No 4 S Direct
American Depositary Shares Disposition 2019-11-04 1,306 $191.32 100 No 4 S Direct
American Depositary Shares Disposition 2019-11-04 100 $192.18 0 No 4 S Direct
American Depositary Shares Acquisiton 2019-11-05 4,000 $41.01 4,000 No 4 M Direct
American Depositary Shares Disposition 2019-11-05 200 $187.38 3,800 No 4 S Direct
American Depositary Shares Disposition 2019-11-05 1,500 $188.71 2,300 No 4 S Direct
American Depositary Shares Disposition 2019-11-05 1,892 $189.56 408 No 4 S Direct
American Depositary Shares Disposition 2019-11-05 208 $190.32 200 No 4 S Direct
American Depositary Shares Disposition 2019-11-04 200 $192.06 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Share Option (Right to Buy) Acquisiton 2019-11-04 52,000 $0.00 52,000 $3.16
Ordinary Shares Share Option (Right to Buy) Acquisiton 2019-11-05 52,000 $0.00 52,000 $3.16
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
117,988 2027-06-01 No 4 M Direct
65,988 2027-06-01 No 4 M Direct
Footnotes
  1. Each American Depositary Share represents 13 Ordinary Shares.
  2. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.92 to $189.89, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.95 to $190.87, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.97 to $191.93, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.89 to $187.79, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.07 to $189.06, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.07 to $190.05, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.15 to $190.9450, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.42 to $192.40, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price.
  11. The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
  12. The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board or otherwise ceases to serve as a director, unless the Board determines otherwise.